Abstract
In this case report a 40-year-old insulin-treated male patient presented with a KCNJ11 R201H mutation, which can cause neonatal diabetes. After initiation of treatment with high doses of the sulfonylurea glibencamide in combination with the glucagon-like peptide 1 receptor agonist liraglutide, insulin treatment of the patient could be terminated. The first nine months after termination of insulin treatment the glycated haemoglobin concentration was 48-54 mmol/mol (i.e. 6.5-7.1%).
| Translated title of the contribution | Successful treatment of KCNJ11 neonatal diabetes without insulin |
|---|---|
| Original language | Danish |
| Journal | Ugeskrift for Laeger |
| Volume | 180 |
| Issue number | 46 |
| ISSN | 0041-5782 |
| Publication status | Published - 12 Nov 2018 |
Fingerprint
Dive into the research topics of 'Successful treatment of KCNJ11 neonatal diabetes without insulin'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS